DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 070098
NDA 070098 describes METHYLDOPA, which is a drug marketed by Accord Hlthcare, Duramed Pharms Barr, Halsey, Ivax Sub Teva Pharms, Mylan, Par Pharm, Parke Davis, Pliva, Purepac Pharm, Roxane, Sun Pharm Industries, Superpharm, Teva, Watson Labs, Yaopharma Co Ltd, Dava Pharms Inc, Sandoz, Abraxis Pharm, Baxter Hlthcare, Hospira, Luitpold, Marsam Pharms Llc, Smith And Nephew, and Teva Parenteral, and is included in ninety-nine NDAs. It is available from seven suppliers. Additional details are available on the METHYLDOPA profile page.
The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.
The generic ingredient in METHYLDOPA is methyldopate hydrochloride. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyldopate hydrochloride profile page.
Summary for 070098
| Tradename: | METHYLDOPA |
| Applicant: | Ivax Sub Teva Pharms |
| Ingredient: | methyldopa |
| Patents: | 0 |
| Therapeutic Class: | Cardiovascular Agents |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 070098
| Mechanism of Action | Adrenergic alpha2-Agonists |
Medical Subject Heading (MeSH) Categories for 070098
Suppliers and Packaging for NDA: 070098
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METHYLDOPA | methyldopa | TABLET;ORAL | 070098 | ANDA | Teva Pharmaceuticals USA Inc | 0093-2931 | N | 0093-2931-01 |
| METHYLDOPA | methyldopa | TABLET;ORAL | 070098 | ANDA | Teva Pharmaceuticals USA Inc | 0093-2931 | N | 0093-2931-10 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Feb 20, 1986 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
